Editing the Code: UCSF's Mission to Cure Sickle Cell Disease with CRISPR
By UCSF Department of Pediatrics on
Engineered Immune Cells May Be Able to Tame Inflammation
By Sarah C.P. Williams on
Immune cells that are designed to soothe could improve treatment for organ transplants, type 1 diabetes and other autoimmune conditions. configuration options
Engineered Receptors Help the Immune System Home in on Cancer
By Sarah C.P. Williams on
UCSF and University of Washington researchers developed synthetic receptors on the surface of immune cells that could make cancer immunotherapies more targeted
UCSF Treats First Patient with Homegrown Chimeric Antigen Receptor (CAR) T-cell Therapy
By Cammie Edwards on
This month marked an important milestone for UCSF faculty and clinicians working to take on the challenge of glioblastoma multiforme (GBM). They treated their first patient with a promising chimeric antigen receptor (CAR) T-cell therapy that was fully conceived, designed, optimized and manufactured…
UCSF Scientists Build a Molecular ‘GPS’ to Guide Cell Therapies
By Levi Gadye on
Wendell Lim earns $30 million contract from ARPA-H to develop a cellular toolkit for therapies targeting diseases of the brain and lung.
New CRISPR Center Brings Hope for Rare and Deadly Genetic Diseases
By Jess Berthold on
CRISPR collaboration combines expertise from three UC schools to scale treatment for diseases that industry has largely passed by – until now.